Mr. Marc Lemieux reports

UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

On Nov. 25, 2025, KDA Group Inc. entered into a share transfer agreement to acquire a 20-per-cent interest in the issued and outstanding shares of its subsidiary, Groupe Technologique KDA Inc. (GTK), currently held by ERxpert Inc.

Under the terms of this agreement, ERxpert has agreed to transfer its shares in the GTK subsidiary to KDA in exchange for 35 million common shares of KDA's share capital.

KDA announces that it received conditional approval from the TSX Venture Exchange for the transaction on Dec. 18, 2025.

Final approval by the TSX Venture Exchange is conditional upon the filing of certain documents and information requested by the TSX Venture Exchange on or before Jan. 20, 2026, and final acceptance by the TSX-V will be issued after satisfactory review of the required documents and information.

About KDA Group Inc.

KDA Group is a leader in technological innovations and specialized software solutions (SaaS -- software as a service) for the health care professional market. KDA is a corporation that offers high-quality products and has recognized and respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate health care's digital transformation and are available for the Canadian and international markets.

We seek Safe Harbor.